How much does a box of Tecfidera cost?
Dimethyl fumarate (Tecfidera) is an oral drug used to treat multiple sclerosis (Multiple Sclerosis, MS), making it an important option for patients to manage this chronic neurological disease.
The original drug of dimethyl fumarate has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. The main foreign drug is dimethyl fumarate original drug. The cheaper one is the Indian original drug, which costs more than 2,000 yuan and has the same composition and efficacy as the domestic original drug.
The main ingredient in Tecfidera is dimethyl fumarate, a compound thought to slow the progression of multiple sclerosis by modulating the activity of the immune system. Its mechanism of action includes inhibiting inflammatory responses and reducing immune cell activity, thereby reducing the risk of nervous system damage.
Compared to some other treatments, Tecfidera offers the convenience of oral administration, making it popular in clinical practice. Patients typically take it twice daily, eliminating the need for injections or intravenous infusions, improving patient compliance.
However, Tecfidera also comes with some potential side effects. During use, some patients may experience gastrointestinal symptoms such as diarrhea, nausea, and abdominal pain. These reactions usually appear early in the medication and gradually subside over a period of time. In addition, some patients may be at more serious risk such as low white blood cell counts, abnormal liver function, and require a comprehensive health assessment before use.
Overall,Tecfiderarepresents an important advance in the treatment of multiple sclerosis, providing patients with an effective oral treatment option. However, during use, patients should pay close attention to any symptoms of discomfort and take medication under the supervision of a doctor to ensure optimal efficacy while minimizing potential risks.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)